Work With Patients To Design Trials For Anti-Hypertensive Devices, FDA Advisors Suggest
Executive Summary
FDA is looking forward to reviewing PMAs from several anti-hypertension devices in the coming years – including technologies from Medtronic, ReCor Medical, ROX Medical, and Vascular Dynamics – so the agency convened its Circulatory System Devices Panel on Dec. 5 to get recommendation on pre-market clinical trial design, post-approval study design, indications and labeling for such devices.
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
